SFCM
COGT icon

Seven Fleet Capital Management’s Cogent Biosciences COGT Stock Holding History

Seven Fleet Capital Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.75M Sell
149,399
-64,700
-30% -$2.39M 1.81% 11
2025
Q4 		$7.6M Buy
+214,099
New +$6.02M 5.15% 2

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Seven Fleet Capital Management's COGT Position: Q1 2026 in Review

Seven Fleet Capital Management reduced its Cogent Biosciences (COGT) stake by 30% in Q1 2026, selling an estimated $2.39M and leaving 149,399 shares worth $5.75M. The position accounts for 1.81% of the portfolio, ranked #11.

Seven Fleet Capital Management first reported a position in COGT in Q4 2025 and has held it in 2 quarters since. The position peaked at $7.6M in Q4 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Seven Fleet Capital Management held 149,399 shares of Cogent Biosciences worth $5.75M as of Q1 2026.
  • Seven Fleet Capital Management sold 64,700 Cogent Biosciences shares in Q1 2026, an estimated $2.39M.
  • Cogent Biosciences made up 1.81% of Seven Fleet Capital Management's portfolio in Q1 2026, its #11 holding.
  • Seven Fleet Capital Management first reported a position in Cogent Biosciences in Q4 2025 and has held it in 2 quarters since.
  • Seven Fleet Capital Management's Cogent Biosciences position peaked at $7.6M in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.